Pharming Group has transitioned from a speculative play to a fundamentally attractive, cash-generating rare disease company.

Neuberg Sehgal PathLab introduces advanced cytogenetics testing for comprehensive cancer diagnosis and prenatal screening: Our Bureau, Mumbai Wednesday, February 4, 2026, 17:30 Hr ...

AbbVie and Medtronic have a long history of raising their dividends and continue to have healthy free cash flow for further dividend growth.

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q4 2025 Earnings Call Transcript February 2, 2026 IDEXX Laboratories, Inc. beats ...

Q4 2025 earnings call highlights: 2026 guidance, CAG Diagnostics growth, inVue Dx/Cancer Dx momentum, margins & risks—read now.

Brain tumors are abnormal growths of cells in or around the brain. They can be primary (originating in the brain) or secondary (metastatic, spreading to the brain from cancer elsewhere). They can also ...

Discover tips for managing swelling, redness, and pain at subcutaneous immunoglobulin (SCIg) infusion sites for primary ...

Participating in the call this morning are Jay Mazelsky, President and Chief Executive Officer, Andrew Emerson, Chief ...

Only the S&P 500 finished higher last week, as it booked a 0.34% gain. The Nasdaq and Dow Jones Industrial Average finished 0 ...

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced fourth quarter and full year results.

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...

British Columbia and Ontario recently added Rezurock® (belumosudil) to their provincial formularies for adult and pediatric patients 12 years and older with chronic graft-versus-host disease (GVHD) ...